GNMX - Aevi Genomic Medicine, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts3233
Avg. Estimate-0.16-0.15-0.87-0.66
Low Estimate-0.16-0.16-0.9-0.68
High Estimate-0.15-0.14-0.85-0.63
Year Ago EPS-0.22-0.29-1.19-0.87
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts2133
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.31-0.27-0.26-0.22
EPS Actual-0.22-0.29-0.22-0.23
Difference0.09-0.020.04-0.01
Surprise %29.00%-7.40%15.40%-4.50%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.16-0.15-0.87-0.66
7 Days Ago-0.16-0.15-0.87-0.66
30 Days Ago-0.18-0.16-0.87-0.71
60 Days Ago-0.18-0.16-0.87-0.74
90 Days Ago-0.18-0.16-0.87-0.74
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1N/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesGNMXIndustrySectorS&P 500
Current Qtr.27.30%N/AN/A-0.00
Next Qtr.48.30%N/AN/A0.08
Current Year26.90%N/AN/A-0.01
Next Year24.10%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A